Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

OBJECT: Gliadel (BCNU) wafer and concomitant temozolomide (TMZ) therapy, when used individually as adjuvant therapies, extend survival from that achieved by resection and radiation therapy (XRT) for glioblastoma multiforme (GBM). It remains unstudied whether combining Gliadel and TMZ therapy is safe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Neurosurg
Asıl Yazarlar: McGirt, Matthew J., Than, Khoi D., Weingart, Jon D., Chaichana, Kaisorn L., Attenello, Frank J., Olivi, Alessandro, Laterra, John, Kleinberg, Lawrence R., Grossman, Stuart A., Brem, Henry, Quiñones-Hinojosa, Alfredo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856017/
https://ncbi.nlm.nih.gov/pubmed/19046047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2008.5.17557
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller